المؤلفون: Mayer-Ferbas, J., Jeindl, R.

مصطلحات موضوعية: QZ 200-380 Neoplasms.Cysts, WA 108-245 Preventive medicine, WR Dermatology

وصف الملف: application/pdf

العلاقة: https://eprints.aihta.at/1514/1/HTA-Informationsdienst_Rapid_Review_014.pdfTest; Mayer-Ferbas, J. and Jeindl, R. (2024): Skin cancer prevention: Guideline recommendations for primary and secondary prevention. Rapid Review Nr.: 014.

الإتاحة: https://eprints.aihta.at/1514Test/
https://eprints.aihta.at/1514/1/HTA-Informationsdienst_Rapid_Review_014.pdfTest

المؤلفون: Rothschedl, E., Grössmann, N.

مصطلحات موضوعية: QV 60-370 Pharmacology, QZ 200-380 Neoplasms.Cysts, WB 300-962 Therapeutics, WR Dermatology

وصف الملف: application/pdf

العلاقة: https://eprints.aihta.at/1507/1/Fact%20Sheet%20Nr.165.pdfTest; Rothschedl, E. and Grössmann, N. (2024): Retifanlimab (Zynyz®) as monotherapy for the first line treatment of patients with metastatic or recurrent locally advanced Merkel cell carcinoma. Fact Sheet Nr. 165.

الإتاحة: https://eprints.aihta.at/1507Test/
https://eprints.aihta.at/1507/1/Fact%20Sheet%20Nr.165.pdfTest

المؤلفون: Burden-Teh, Esther

مصطلحات موضوعية: 618.92, WR Dermatology

الوصول الحر: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.823381Test

المؤلفون: Rothschedl, E., Grössmann, N.

مصطلحات موضوعية: QV 60-370 Pharmacology, QZ 200-380 Neoplasms.Cysts, WB 300-962 Therapeutics, WR Dermatology

وصف الملف: application/pdf

العلاقة: https://eprints.aihta.at/1468/1/Fact%20Sheet%20Nr.144_Update.pdfTest; Rothschedl, E. and Grössmann, N. (2023): Nivolumab (Opdivo®) as monotherapy for the adjuvant treatment of Stage IIB or IIC melanoma, or melanoma with involvement of lymph nodes or metastatic disease. Update July/August 2023. Fact Sheet Nr. 144.

الإتاحة: https://eprints.aihta.at/1468Test/
https://eprints.aihta.at/1468/1/Fact%20Sheet%20Nr.144_Update.pdfTest

المؤلفون: Rothschedl, E., Wolf, S.

مصطلحات موضوعية: QV 60-370 Pharmacology, QZ 200-380 Neoplasms.Cysts, WB 300-962 Therapeutics, WR Dermatology

وصف الملف: application/pdf

العلاقة: https://eprints.aihta.at/1403/1/Oncology%20Fact%20Sheet%20Nr.105_Update.pdfTest; Rothschedl, E. and Wolf, S. (2022): Relatlimab/nivolumab (Opdualag®) for the first line treatment of advanced melanoma in adults and adolescents 12 years of age and older with tumour cell PD-L1 expression < 1%. Update December 2022. Oncology Fact Sheet Nr. 105.

الإتاحة: https://eprints.aihta.at/1403Test/
https://eprints.aihta.at/1403/1/Oncology%20Fact%20Sheet%20Nr.105_Update.pdfTest

المؤلفون: Simpson, Rosalind C.

مصطلحات موضوعية: 616.5, WR Dermatology

الوصول الحر: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.668612Test

المؤلفون: Lansbury, Louise E.

مصطلحات موضوعية: 616.99, WR Dermatology

الوصول الحر: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.639914Test

المؤلفون: Eleftheriadou, Viktoria

مصطلحات موضوعية: 616.55, WR Dermatology

الوصول الحر: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.580248Test

المؤلفون: Wolf, S.

مصطلحات موضوعية: QV 60-370 Pharmacology, QZ 200-380 Neoplasms.Cysts, WB 300-962 Therapeutics, WR Dermatology

وصف الملف: application/pdf

العلاقة: https://eprints.aihta.at/1317/1/Oncology%20Fact%20Sheet%20Nr.53_Update.pdfTest; Wolf, S. (2021): Cemiplimab (Libtayo®) as monotherapy for the treatment of locally advanced or metastatic basal cell carcinoma (laBCC or mBCC). Update September 2021. Oncology Fact Sheet Nr. 53.

الإتاحة: https://eprints.aihta.at/1317Test/
https://eprints.aihta.at/1317/1/Oncology%20Fact%20Sheet%20Nr.53_Update.pdfTest

المؤلفون: Kashkouli, M.B., Karimi, N., Johari-Moghadam, M.-M., Shayanfar, N., Aghamirsalim, M., Abdolalizadeh, P.

مصطلحات موضوعية: WR Dermatology

العلاقة: Kashkouli, M.B. and Karimi, N. and Johari-Moghadam, M.-M. and Shayanfar, N. and Aghamirsalim, M. and Abdolalizadeh, P. (2021) Dermatochalasis Through Decades: A Histopathologic Study. Annals of plastic surgery, 86 (3). pp. 340-344.

الإتاحة: http://eprints.iums.ac.ir/39750Test/